- TypeConference
- Location Philadelphia, Pennsylvania, United States
- Date 20-06-2019 - 21-06-2019
Medical/Healthcare/Hospital
IO Combinations 360° provides the most up-to-date research, data and progress on combination developments to help IO stakeholders:
- Be at the forefront of the most relevant research and developments for IO combinations from key leadership who are at the pulse of cancer immunotherapy
- Foster collaboration amongst others working in all aspects of cancer immunotherapy by rounding up all stakeholders under one roof
- Receive the latest pre-clinical, translational and clinical data from academia and industry
- Better understand what assets are available for potential combinations that may be able to give patients more treatment options
- Create and prioritize combination strategies targeted toward specific tumor types
- Get key investor and analyst evaluations and insights on the IO combination landscape
- Learn about biomarker advancements, neoantigen approaches and more
- Obtain coverage on a wide range of emerging technologies
Key topics for 2019 include:
- Discovery / Preclinical Science
- Bispecifics
- Translational Science and Biomarkers
- Next Generation Cell Therapy
- Clinical Developments
- Operationalizing Combinations
- Business Aspects
- Emerging Technologies
Speakers: Jon Armstrong, Julie Bailis, PhD, Roy Baynes, MD, PhD, Justine Cohen, DO, Asthika Goonewardene, Omid Hamid and many more. Time: 8:00 am to 4:00 pm